Download presentation
Presentation is loading. Please wait.
Published bySudomo Setiabudi Modified over 6 years ago
1
Role of nasal nitric oxide in the resolution of experimental rhinovirus infection
Scherer P Sanders, PhD, David Proud, PhD, Solbert Permutt, MD, Edward S Siekierski, BS, Robin Yachechko, BS, Mark C Liu, MD Journal of Allergy and Clinical Immunology Volume 113, Issue 4, Pages (April 2004) DOI: /j.jaci
2
Fig 1 Symptom scores and viral titers for nasal lavage samples: see the “Methods” section (mean±SEM, n=6). Journal of Allergy and Clinical Immunology , DOI: ( /j.jaci )
3
Fig 2 Differential counts performed on cells recovered from nasal lavage fluid: lymph, lymphocytes; mono, monocytes; pmn, neutrophils; eo, eosinophils (mean±SEM, n=6). ∗P<.05. Journal of Allergy and Clinical Immunology , DOI: ( /j.jaci )
4
Fig 3 Comparison of the wall concentration of eNO measured from the lower airways and nose (see the “Methods” section) of subjects during experimental HRV infection. Data expressed as a percentage of the baseline value (mean±SEM, n=6). Journal of Allergy and Clinical Immunology , DOI: ( /j.jaci )
5
Fig 4 A, Standard curve for real-time RT-PCR of NOS2 by using first-strand cDNA standard (mean±SEM, n=3). B, Correlation of nasal NOS2 mRNA and increases in concentration of nasal eNO on day 3 after HRV infection (n=5, insufficient sample in one subject). Journal of Allergy and Clinical Immunology , DOI: ( /j.jaci )
6
Fig 5 Symptom scores on day 4 were inversely correlated with the concentration of nasal eNO (n=6). Journal of Allergy and Clinical Immunology , DOI: ( /j.jaci )
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.